Table 1.
Cont | Amalgam (A) | Amalgam + Implants (A + I) | KW | |
---|---|---|---|---|
IL-1 β (pg/mL) | 11.03 ± 0.48 | 11.03 ± 0.32 | 12.66 ± 0.52 # | H = 9.37, p = 0.009 |
MCP-1 (pg/mL) | 9.48 ± 0.7 | 10.39 ± 0.24 | 11.76 ± 0.14 *,# | H = 22.88, p < 0.001 |
CX3CL1 (pg/mL) | 30.02 ± 2.7 | 34.3 ± 7.1 | 98 ± 3.6 *,# | F (2, 140) = 5, p = 0.01 |
IL-4 (pg/mL) | 40 ± 1.3 | 42 ± 1.1 | 37.8 ± 1.7 # | F (2, 140) = 2.63, p = 0.082 |
IL 1 Beta/Il-4 ratio | 0.28 ± 0.01 | 0.26 ± 0.011 | 0.32 ± 0.02 # | H (4, 140), p = 0.091, n.s |
Kyn | 1.47 ± 0.09 | 1.68 ± 0.1 | 2.09 ± 0.14 *,# | F (2, 140) = 5.96, p = 0.035 |
Kyn/L-Trp ratio | 31 ± 2.3 | 27 ± 2.5 | 47 ± 3.3 *,# | F (2, 140) = 14.6, p < 0.001 |
* p < 0.05 vs. Cont, # p < 0.05 vs. Amalgam (A).